Postprandial glucose regulation and diabetic complications

被引:268
作者
Ceriello, A
Hanefeld, M
Leiter, L
Monnier, L
Moses, A
Owens, D
Tajima, N
Tuomilehto, J
机构
[1] Univ Udine, Dept Pathol & Med Expt & Clin, I-33100 Udine, Italy
[2] Tech Univ Dresden, Ctr Clin Studies, Dresden, Germany
[3] Univ Toronto, St Michaels Hosp, Div Endocrinol & Metab, Toronto, ON, Canada
[4] Lapeyronie Hosp, Dept Metab, Montpellier, France
[5] Joslin Diabet Ctr, Boston, MA USA
[6] Llandough Hosp, Diabet Res Unit Acad Ctr, Penarth, S Glam, Wales
[7] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Tokyo, Japan
[8] Natl Publ Hlth Inst, Diabet & Genet Epidemiol Unit, Helsinki, Finland
关键词
D O I
10.1001/archinte.164.19.2090
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerotic disease accounts for much of the increased mortality and morbidity associated with type 2 diabetes. Epidemiological studies support the potential of improved glycemic control to reduce cardiovascular complications. An association between glycosylated hemoglobin (HbA(1c)) level and the risk for cardiovascular complications has frequently been reported. Most epidemiological data implicate postprandial hyperglycemia in the development of cardiovascular disease, whereas the link between fasting glycemia and diabetic complications is inconclusive. Moreover, in many studies, postprandial glycemia is a better predictor of cardiovascular risk than HbA(1c) level. Postprandial glucose may have a direct toxic effect on the vascular endothelium, mediated by oxidative stress that is independent of other cardiovascular risk factors such as hyperlipidemia. Postprandial hyperglycemia also may exert its effects through its substantial contribution to total glycemic exposure. The present review examines the hypothesis that controlling postprandial glucose level is an important strategy in the prevention of cardiovascular complications associated with diabetes.
引用
收藏
页码:2090 / 2095
页数:6
相关论文
共 59 条
  • [1] MANAGEMENT OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS IN EUROPE - A CONSENSUS VIEW
    ALBERTI, KGMM
    GRIES, FA
    [J]. DIABETIC MEDICINE, 1988, 5 (03) : 275 - 281
  • [2] *AM COLL END, 2002, ENDOCR PRACT S1, V8, P5
  • [3] *AM DIAB ASS, 2004, DIABETES CARE S1, V27, pS15
  • [4] American Diabetes Association, 2001, Diabetes Care, V24, P775
  • [5] [Anonymous], 1996, DIABETES, V45, P1289
  • [6] Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes
    Avignon, A
    Radauceanu, A
    Monnier, L
    [J]. DIABETES CARE, 1997, 20 (12) : 1822 - 1826
  • [7] High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men -: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study
    Balkau, B
    Shipley, M
    Jarrett, RJ
    Pyörälä, K
    Pyörälä, M
    Forhan, A
    Eschwège, E
    [J]. DIABETES CARE, 1998, 21 (03) : 360 - 367
  • [8] Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men - The Rancho Bernardo Study
    Barrett-Connor, E
    Ferrara, A
    [J]. DIABETES CARE, 1998, 21 (08) : 1236 - 1239
  • [9] Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c
    Bastyr, EJ
    Stuart, CA
    Brodows, RG
    Schwartz, S
    Graf, CJ
    Zagar, A
    Robertson, KE
    [J]. DIABETES CARE, 2000, 23 (09) : 1236 - 1241
  • [10] Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes -: Implications for treatment and monitoring of metabolic control
    Bonora, E
    Calcaterra, F
    Lombardi, S
    Bonfante, N
    Formentini, G
    Bonadonna, RC
    Muggeo, M
    [J]. DIABETES CARE, 2001, 24 (12) : 2023 - 2029